SCHEMBL28111658

SCHEMBL28111658

Cc1cc(OC=O)ccc1OC(C)C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A3 P47895 1/20 0.42
CYP1A2 P05177 1/20 0.41
MAPT P10636 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
TDP1 Q9NUW8 1/20 0.38
TSHR P16473 1/20 0.37
HTR2A P28223 1/20 0.37
HTR2C P28335 1/20 0.37
HTR2B P41595 1/20 0.37
ALDH1A1 P00352 2/20 0.36
KDM4E B2RXH2 1/20 0.36
HPGD P15428 1/20 0.36
HSD17B10 Q99714 1/20 0.36
SENP2 Q9HC62 1/20 0.35
SENP1 Q9P0U3 1/20 0.35
FFAR4 Q5NUL3 3/20 0.35
ERN1 O75460 1/20 0.35
IRAK4 Q9NWZ3 1/20 0.34
HTT P42858 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16606251 0.81 ALDH1A1 (0.46) ALDH1A3MAPTTDP1TSHRHTR2A
SCHEMBL14579646 0.80 ALDH1A1 (0.43) CYP1A2MAPTTDP1TSHRALDH1A1
SCHEMBL1911936 0.78 CA12 (0.48) MAPTHTR2AALDH1A1KDM4EHTT
SCHEMBL26109321 0.78 XDH (0.46)
SCHEMBL15298623 0.78 JUN (0.38) ALDH1A3CYP1A2MAPTCYP2C9CYP2C19
SCHEMBL26245660 0.78 RXRA (0.47) ALDH1A3CYP1A2MAPTCYP2C9CYP2C19
SCHEMBL3631030 0.75 ALDH1A3 (0.63) ALDH1A3TSHRALDH1A1ERN1KMT2A
SCHEMBL8611737 0.75 TDP1 (0.46) MAPTTDP1ALDH1A1KDM4EHPGD
SCHEMBL4010865 0.75 TDP1 (0.36) ALDH1A3CYP1A2MAPTCYP2C9CYP2C19
SCHEMBL12476044 0.75 ALDH1A3 (0.53) ALDH1A3CYP1A2MAPTCYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103517910-B Morpholine-spirocyclic piperidine amides as modulators of ion channels 沃泰克斯药物股份有限公司 2016-12-14 CN disclosed